May 7
Earnings call
Q1 2024 earnings call
MD · Pediatrix Medical Group, Inc. · Documents
$31.28
-0.01 (-0.03%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$2.44B
Shares
78.12M
Volume · Nov 9
40.14K
Avg daily vol (3M)
753.2K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2024
May 7
Current report
8-K
Financial results
May 7
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $495.1M
▲ 0.8%
Net income $4.04M
▼ 71.6%
Diluted EPS $0.05
▼ 70.6%
Apr 25
Current report
8-K
Events of Apr 19
Entered into a material agreement
Mar 28
Proxy statement
DEF 14A
Meeting May 9, 2024
Proxy statement
Mar 28
Annual report to holders
ARS
Annual report to holders
Mar 28
Proxy statement
DEFA14A
Proxy statement
Feb 20
Earnings call
Q4 2023 earnings call
Feb 20
Current report
8-K
Financial results
Feb 20
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Revenue $1.99B
▲ 1.1%
Net loss $60.41M
Diluted EPS $0.73
▼ 7.6%
2023
Nov 2
Earnings call
Q3 2023 earnings call
Nov 2
Current report
8-K
Financial results
Nov 2
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $506.61M
▲ 3.4%
Net income $21.39M
▼ 30.4%
Diluted EPS $0.26
▼ 29.7%
Aug 3
Earnings call
Q2 2023 earnings call
Aug 3
Current report
8-K
Financial results
Aug 3
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $500.58M
▲ 3.0%
Net income $28.28M
▲ 4.2%
Diluted EPS $0.34
▲ 6.3%
May 11
Current report
8-K
Shareholder vote results
May 4
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
May 2
Earnings call
Q1 2023 earnings call
May 2
Current report
8-K
Financial results
May 2
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $491.01M
▲ 1.8%
Net income $14.21M
Diluted EPS $0.17
Mar 31
Proxy statement
DEF 14A
Proxy statement
Mar 31
Annual report to holders
ARS
Annual report to holders
Mar 31
Proxy statement
DEFA14A
Proxy statement
Mar 8
Current report
8-K
Events of Mar 7
Director or officer change, or executive pay
Feb 17
Earnings call
Q4 2022 earnings call
Feb 17
Current report
8-K
Financial results
Feb 17
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Revenue $1.97B
▲ 3.2%
Net income $66.34M
▼ 49.3%
Diluted EPS $0.79
▼ 48.4%
2022
Dec 16
Current report
8-K
Events of Dec 15
Director or officer change, or executive pay, Regulation FD disclosure
Nov 3
Earnings call
Q3 2022 earnings call
Nov 3
Current report
8-K
Financial results
Nov 3
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $489.92M
▼ 0.6%
Net income $30.73M
▼ 0.2%
Diluted EPS $0.37
▲ 2.8%
Sep 23
Current report
8-K
Events of Sep 19
Director or officer change, or executive pay
Aug 4
Earnings call
Q2 2022 earnings call
Aug 4
Current report
8-K
Financial results
Aug 4
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $486.03M
▲ 2.8%
Net income $27.14M
▼ 22.5%
Diluted EPS $0.32
▼ 22.0%
Jun 21
Current report
8-K
Regulation FD disclosure
May 17
Current report
8-K
Events of May 12
Director or officer change, or executive pay, Shareholder vote results
Apr 28
Earnings call
Q1 2022 earnings call
Apr 28
Current report
8-K
Financial results
Apr 28
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $482.23M
▲ 7.9%
Net loss $21.19M
Diluted EPS -$0.25
Apr 1
Proxy statement
DEF 14A
Meeting May 12, 2022
Proxy statement
Apr 1
Proxy statement
DEFA14A
Proxy statement
Mar 21
Proxy statement
PRE 14A
Meeting May 12, 2022
Proxy statement
Feb 25
Current report
8-K
Events of Feb 23
Director or officer change, or executive pay
Feb 17
Earnings call
Q4 2021 earnings call
Feb 17
Current report
8-K
Financial results
Feb 17
Annual report
10-K
FY2021, ended Dec 31
Annual report for FY2021
Revenue $1.91B
▲ 10.2%
Net income $130.96M
Diluted EPS $1.53
Feb 14
Current report
8-K
Events of Feb 11
Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure
2021
Nov 19
Current report
8-K
Events of Nov 16
Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events
Showing 51–100 of 149 documents
Key facts
CIK
893949
CUSIP
58502B106
13F (30d)
149 filings
128 filers
Visit website
Investor relations